Cell-free Lactiplantibacillus plantarum OC01 supernatant suppresses IL-6-induced proliferation and invasion of human colorectal cancer cells: Effect on β-Catenin degradation and induction of autophagy

10.1016/j.jtcme.2023.02.001

Letizia Vallino；Beatrice Garavaglia；Annalisa Visciglia；Angela Amoruso；Marco Pane；Alessandra Ferraresi；Ciro Isidoro

Probiotics ； Microbiota ； Colorectal cancer ； Inflammation ； Butyrate ； β-Catenin ； Autophagy ； Cell proliferation ； Cell migration

Journal of Traditional and Complementary Medicine

13卷2期（2023 / 03 / 01）

193 - 206

英文

Background and aim: Gut microbiota is considered as a complex organ of human body. The interaction between the host and microbiota is dynamic and controlled by a huge number of factors, such as lifestyle, geography, pharmaceuticals, diet, and stress. The breakdown of this relationship could change microbiota composition favoring the onset of several diseases, including cancer. Metabolites released by microbiota bacterial strains have been reported to elicit protective effects on the mucosa that could contrast cancer development and progression. Here, we tested the ability of specific probiotic strain Lactiplantibacillus plantarum OC01-derived metabolites (NCIMB 30624) to contrast the malignant features of colorectal cancer (CRC) cells. Experimental procedure: The study was performed on two cell lines, HCT116 and HT29, cultured in 2D and 3D, and focused on the hallmarks of cell proliferation and migration. Results and conclusion: Probiotic metabolites reduced cell proliferation both in 2D and 3D-spheroid cultures, the latter model mimicking the growth in vivo. The bacterial metabolites also contrasted the pro-growth and pro-migratory activity of inteurleukin-6 (IL-6), an inflammatory cytokine abundantly found in the tumor microenvironment of CRC. These effects were associated with inhibition of the ERK and of the mTOR/p70S6k pathways and with the inhibition of the E-to N-Cadherin switch. In a parallel study, we found that sodium butyrate (a representative of the main probiotic metabolites) induced autophagy and β-Catenin degradation, which is consistent with the growth inhibitory activity. The present data indicate that the metabolites of Lactiplantibacillus plantarum OC01 (NCIMB 30624) elicits anti-tumor effect and support its possible inclusion as adjuvant therapy of CRC for limiting cancer growth and progression.

1. Alam, Z,Shang, X,Effat, K(2022).The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer.J Food Biochem,46(10),e14302.
2. Arnold, M,Sierra, MS,Laversanne, M,Soerjomataram, I,Jemal, A,Bray, F(2017).Global patterns and trends in colorectal cancer incidence and mortality.Gut,66(4),683-691.
3. Bian, J,Dannappel, M,Wan, C,Firestein, R(2020).Transcriptional regulation of wnt/βcatenin pathway in colorectal cancer.Cells,9(9),2125.
4. Biever, A,Valjent, E,Puighermanal, E(2015).Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function.Front Mol Neurosci,8,75.
5. Boettcher, S,Miller, PG,Sharma, R(2019).A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.Science,365(6453),599-604.
6. Campomenosi, P,Monti, P,Aprile, A(2001).p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.Oncogene,20(27),3573-3579.
7. Cargnello, M,Tcherkezian, J,Roux, PP(2015).The expanding role of mTOR in cancer cell growth and proliferation.Mutagenesis,30(2),169-176.
8. Degirmenci, U,Wang, M,Hu, J(2020).Targeting aberrant RAS/RAF/MEK/ERK signaling for cancer therapy.Cells,9(1),198.
9. den Besten, G,van Eunen, K,Groen, AK,Venema, K,Reijngoud, DJ,Bakker, BM(2013).The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism.J Lipid Res,54(9),2325-2340.
10. Dikeocha, IJ,Al-Kabsi, AM,Chiu, HT,Alshawsh, MA(2022).Faecalibacterium prausnitzii ameliorates colorectal tumorigenesis and suppresses proliferation of HCT116 colorectal cancer cells.Biomedicines,10(5),1128.
11. Esposito, A,Ferraresi, A,Salwa, A,Vidoni, C,Dhanasekaran, DN,Isidoro, C(2022).Resveratrol contrasts IL-6 pro-growth effects and promotes autophagymediated cancer cell dormancy in 3D ovarian cancer: role of miR-1305 and of its target ARH-I.Cancers,14(9),2142.
12. Fareez, IM,Lim, SM,Ramasamy, K(2022).Chemoprevention by microencapsulated Lactiplantibacillus plantarum LAB12 against orthotopic colorectal cancer mice is associated with apoptosis and anti-angiogenesis.Probiotics Antimicrob Proteins
13. Ferraresi, A,Esposito, A,Girone, C(2021).Resveratrol contrasts LPA-induced ovarian cancer cell migration and platinum resistance by rescuing hedgehogmediated autophagy.Cells,10(11),3213.
14. Ferraresi, A,Phadngam, S,Morani, F(2017).Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.Mol Carcinog,56(3),1164-1181.
15. Foran, E,Garrity-Park, MM,Mureau, C(2010).Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6.Mol Cancer Res,8(4),471-481.
16. Freed-Pastor, WA,Prives, C(2012).Mutant p53: one name, many proteins.Genes Dev,26(12),1268-1286.
17. Garavaglia, B,Vallino, L,Ferraresi, A(2022).Butyrate inhibits colorectal cancer cell proliferation through autophagy degradation of b-catenin regardless of APC and β-catenin mutational status.Biomedicines,10(5),1131.
18. Giguère, V(2018).Canonical signaling and nuclear activity of mTOR-a teamwork effort to regulate metabolism and cell growth.FEBS J,285(9),1572-1588.
19. Gomaa, EZ(2020).Human gut microbiota/microbiome in health and diseases: a review.Antonie Leeuwenhoek,113(12),2019-2040.
20. Guiomar de Almeida Brasiel, P,Cristina Potente Dutra Luquetti, S,Dutra Medeiros, J(2022).Kefir modulates gut microbiota and reduces DMH-associated colorectal cancer via regulation of intestinal inflammation in adulthood offsprings programmed by neonatal overfeeding.Food Res Int,152,110708.
21. Keku, TO,Dulal, S,Deveaux, A,Jovov, B,Han, X(2015).The gastrointestinal microbiota and colorectal cancer.Am J Physiol Gastrointest Liver Physiol,308(5),G351-G363.
22. Knüpfer, H,Preiss, R(2010).Serum interleukin-6 levels in colorectal cancer patients–a summary of published results.Int J Colorectal Dis,25(2),135-140.
23. Laplante, M,Sabatini, DM(2012).mTOR signaling in growth control and disease.Cell,149(2),274-293.
24. Linnskog, R,Jönsson, G,Axelsson, L,Prasad, CP,Andersson, T(2014).Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.Mol Oncol,8(8),1365-1378.
25. Longley, DB,Allen, WL,Johnston, PG(2006).Drug resistance, predictive markers and pharmacogenomics in colorectal cancer.Biochim Biophys Acta,1766(2),184-196.
26. Ma, F,Sun, M,Song, Y(2022).Lactiplantibacillus plantarum-12 alleviates inflammation and colon cancer symptoms in AOM/DSS-Treated mice through modulating the intestinal microbiome and metabolome.Nutrients,14(9),1916.
27. Ma, L,Chen, Z,Erdjument-Bromage, H,Tempst, P,Pandolfi, PP(2005).Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.Cell,121(2),179-193.
28. Mirza-Aghazadeh-Attari, M,Ekrami, EM,Aghdas, SAM(2020).Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: implication for cancer therapy.Life Sci,255,117481.
29. Molska, M,Reguła, J(2019).Potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer.Nutrients,11(10),2453.
30. Nemati, M,Omrani, GR,Ebrahimi, B,Montazeri-Najafabady, N(2021).The beneficial effects of probiotics via autophagy: a systematic review.BioMed Res Int,2021,2931580.
31. Panebianco, C,Latiano, T,Pazienza, V(2020).Microbiota manipulation by probiotics administration as emerging tool in cancer prevention and therapy.Front Oncol.,10,679.
32. Panebianco, C,Potenza, A,Andriulli, A,Pazienza, V(2018).Exploring the microbiota to better understand gastrointestinal cancers physiology.Clin Chem Lab Med,56(9),1400-1412.
33. Parida, S,Sharma, D(2021).The microbiome and cancer: creating friendly neighborhoods and removing the foes within.Cancer Res,81(4),790-800.
34. Petersen, C,Round, JL(2014).Defining dysbiosis and its influence on host immunity and disease.Cell Microbiol,16(7),1024-1033.
35. Plaza-Diaz, J,Ruiz-Ojeda, FJ,Gil-Campos, M,Gil, A(2019).Mechanisms of action of probiotics.Adv Nutr,10(suppl_1),S49-S66.
36. Privitera, G,Rana, N,Scaldaferri, F,Armuzzi, A,Pizarro, TT(2022).Novel insights into the interactions between the gut microbiome, inflammasomes, and gasdermins during colorectal cancer.Front Cell Infect Microbiol,11,806680.
37. Roskoski, R, Jr(2019).Targeting ERK1/2 protein-serine/threonine kinases in human cancers.Pharmacol Res,142,151-168.
38. Roy, S,Trinchieri, G(2017).Microbiota: a key orchestrator of cancer therapy.Nat Rev Cancer,17(5),271-285.
39. Song, M,Chan, AT(2019).Environmental factors, gut microbiota, and colorectal cancer prevention.Clin Gastroenterol Hepatol,17(2),275-289.
40. Song, M,Chan, AT,Sun, J(2020).Influence of the gut microbiome, diet, and environment on risk of colorectal cancer.Gastroenterology,158(2),322-340.
41. Thiery, JP,Sleeman, JP(2006).Complex networks orchestrate epithelial-mesenchymal transitions.Nat Rev Mol Cell Biol,7(2),131-142.
42. Thongchot, S,Ferraresi, A,Vidoni, C(2018).Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.Cancer Lett,430,160-171.
43. Toyoshima, Y,Kitamura, H,Xiang, H(2019).IL6 modulates the immune status of the tumor microenvironment to facilitate metastatic colonization of colorectal cancer cells.Cancer Immunol Res,7(12),1944-1957.
44. Van Cutsem, E,Cervantes, A,Nordlinger, B,Arnold, D,ESMO Guidelines Working Group(2014).Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol,25(Suppl 3:iii),1-9.
45. Van Cutsem, E,Nordlinger, B,Cervantes, A,ESMO Guidelines Working Group(2010).Advanced colorectal cancer: ESMO clinical practice guidelines for treatment.Ann Oncol.,21(Suppl 5),v93-v97.
46. Vu, T,Datta, PK(2017).Regulation of EMT in colorectal cancer: a culprit in metastasis.Cancers,9(12),171.
47. Waldner, MJ,Foersch, S,Neurath, MF(2012).Interleukin-6–a key regulator of colorectal cancer development.Int J Biol Sci.,8(9),1248-1253.
48. Wang, K,Karin, M(2015).Tumor-elicited inflammation and colorectal cancer.Adv Cancer Res,128,173-196.
49. Wang, Y,Li, J,Ma, C(2021).Lactiplantibacillus plantarum HNU082 inhibited the growth of Fusobacterium nucleatum and alleviated the inflammatory response introduced by F. nucleatum invasion.Food Funct,12(21),10728-10740.
50. Yang, L,Liu, C,Zhao, W(2018).Impaired autophagy in intestinal epithelial cells alters gut microbiota and host immune responses.Appl Environ Microbiol,84(18),18.
51. Zegarra, Ruiz DF,Kim, DV,Norwood, K(2022).Microbiota manipulation to increase macrophage IL-10 improves colitis and limits colitis-associated colorectal cancer.Gut Microb,14(1),2119054.
52. Zeng, X,Jia, H,Shi, Y(2022).Lactobacillus kefiranofaciens JKSP109 and Saccharomyces cerevisiae JKSP39 isolated from Tibetan kefir grain co-alleviated AOM/DSS induced inflammation and colorectal carcinogenesis.Food Funct,13(13),6947-6961.